Public research preview

Gilbert Cisneros, Representative disclosure: 17 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

Disclosed a sell transaction in 17 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Vorsicht beim Hinterherlaufen
49/100
Signalqualität
34/100
Datenqualität
93%
Hohe Qualität

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
4 Sept 2026, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
36 days

Zeitleiste

Transaktionsdatum

30 Jul 2026

Öffentliche Meldung

4 Sept 2026

Jetzt

Heute verfolgt

Meldeverzug: 36 Tage

Kursbewegung

Teilabdeckung

Anbieter
Yahoo Finance daily close
Abgerufen
7. Sept. 2026

Missing Yahoo Finance daily close for transaction date 2026-07-30, disclosure date 2026-09-04.

Kursverlauf

CRNX vom Kontext vor der Transaktion bis zum letzten Schlusskurs.

Neueste

2. Sept. 2026 · 84,95 USD · Noch nicht öffentlich

Systementscheidung

Würde nicht kaufenDie Filter der Strategie lehnen dieses Signal ab. Nicht bestandene Filter: Buy disclosure · Filed within 30 days · Pre-disclosure move <= 35%.

Noch nicht öffentlich84,884,984,9USDDatum20. Aug.24. Aug.2. Sept.Official disclosure4. Sept.Neueste
  • Noch nicht öffentlich
  • Würde nicht kaufen
Fallback-Kurs zur Transaktion
Fallback-Kurs zur Meldung
Neuester Fallback-Kurs
Bewegung vor Meldung
Bewegung nach Meldung
Marktbereinigte Bewegung
1w since disclosure
1m since disclosure
3m since disclosure
Spitzenanstieg vor Meldung
+0,2 %
Rückgang vom Hoch
0,0 %

Why Copy Window is Be careful chasing

Supporting factors

  • Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $15,001 - $50,000.
  • Post-disclosure move is currently treated as 0% because market-price coverage is unavailable.

Cautions

  • Missing Yahoo Finance daily close for transaction date 2026-07-30, disclosure date 2026-09-04.
  • Copy Window is using a transaction-price fallback until coverage improves.
  • Price coverage is partial; accepted for official-source intake before market data enrichment.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 4 Sept 2026, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidesell
value15001
sourcehouse_stock_act
tickerCRNX
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035190.pdf
personNameGilbert Cisneros
amountRange$15,001 - $50,000
companyNameCrinetics Pharmaceuticals, Inc. - Common Stock (CRNX)
publishedAt2026-09-04T00:00:00.000Z
rawDocumentIdraw-us-house-20035190-16
disclosureDate2026-09-04
transactionDate2026-07-30
transactionTypeS